<!DOCTYPE html>
<html lang="en">
  
<!-- Mirrored from www.allindianpatents.com/patents/228117-an-electrotransport-device by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 08:41:19 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Indian Patents. 228117:AN ELECTROTRANSPORT DEVICE</title>
    <meta content="authenticity_token" name="csrf-param" />
<meta content="cYcP52B8zyTWKbLwby2YPh9z/gvY/RLjWOwY4YXkiXg=" name="csrf-token" />

    <!-- Le HTML5 shim, for IE6-8 support of HTML elements -->
    <!--[if lt IE 9]>
      <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.6.1/html5shiv.js" type="text/javascript"></script>
    <![endif]-->

    <link href="../assets/application-e80cf34975c5b1730c80b2f7170e7d26.css" media="all" rel="stylesheet" type="text/css" />

  </head>
  <body>

    <div class="navbar navbar-fluid-top">
      <div class="navbar-inner">
        <div class="container-fluid">
          <a class="btn btn-navbar" data-target=".nav-collapse" data-toggle="collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </a>
          <a class="brand" href="../index.html">Indian Patents</a>
          <div class="container-fluid nav-collapse">
            <ul class="nav">
              <li><a href="../recently-granted.html">Recently Granted Patents</a></li>
              <li><a href="../recently-published.html">Recently Published Patents</a></li>
            </ul>
            <form id="gform" class="navbar-search pull-right" action="https://www.google.com/search" method="get" target="_blank" onsubmit="document.getElementById('gform').q.value='site:http://www.allindianpatents.com '+document.getElementById('gform').q.value">
                <input type="text" name="q" id="q" class="search-query" placeholder="Search" onclick="this.value=''" autocomplete="off">
            </form>
          </div><!--/.nav-collapse -->
        </div>
      </div>
    </div>

    <div class="container-fluid">
      <div class="row-fluid">
        <div class="span12">

          <style>
          .allindianpatents-top { width: 320px; height: 50px; }
          @media(min-width: 500px) { .allindianpatents-top { width: 468px; height: 60px; } }
          @media(min-width: 800px) { .allindianpatents-top { width: 728px; height: 90px; } }
          </style>
          <center>
          </center>
          
          <div class="row-fluid">
	<div class="span8">

		<table class="table">
			<tr>
				<th>Title of Invention</th>
				<td><h1 style="font-size:large;">AN ELECTROTRANSPORT DEVICE</h1></td>
			</tr>
			<tr>
				<th>Abstract</th>
				<td>This invention relates to an electrotransport device comprising; a reservoir and a non-conductive housing for the reservoir that comprises a substantially flexible electrically conductive element integrally molded within the non-conductive housing, wherein a first portion of the conductive element is within the non- conductive housing and a second portion of the element is disposed on the outside of the non-conductive housing and extends thereform, and wherein a substantially liquid and moisture-impermeable bond is created between the material forming the non-conductive housing and the conductive element.</td>
			</tr>
		</table>

					<style>
					.allindianpatents-post-abstract { width: 320px; height: 50px; }
					@media(min-width: 880px) { .allindianpatents-post-abstract { width: 468px; height: 60px; } }
					@media(min-width: 1267px) { .allindianpatents-post-abstract { width: 728px; height: 90px; } }
					</style>
					<center>
					<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
					<!-- AllIndianPatents-post-abstract -->
					<ins class="adsbygoogle allindianpatents-post-abstract"
					     style="display:inline-block"
					     data-ad-client="ca-pub-7914358224572760"
					     data-ad-slot="9152759240"></ins>
					<script>
					(adsbygoogle = window.adsbygoogle || []).push({});
					</script>					
					</center>

		<table class="table">
			<tr>
				<th>Full Text</th>
				<td>FIELD OF INVENTION<br>
The present invention relates to an electrotransport device having a reservoir<br>
housing having a flexible electrically conductive element integrally molded within<br>
the generally non-conductive housing. This flexible/bendable electrically<br>
conductive element allows an electrical connection to be made across the<br>
reservoir housing without physically passing cables or wires through an opening<br>
in the housing.<br>
BACKGROUND OF INVENTION<br>
The term 'electrotransport refers generally to the delivery or extraction of a<br>
therapeutic agent (charged, uncharged, or mixtures thereof) through a body<br>
surface (such as skin, mucous membrane, or nails) wherein the delivery or<br>
extraction is at least partially induced or aided by the application of an electric<br>
potential. The electrotransport process has been found to be useful in the<br>
transdermal administration of many drugs including lidocaine, hydrocortisone,<br>
fluoride, penicillin, and dexamethasone. A common use of electrotransport is in<br>
diagnosing cystic fibrosis by delivering pilocarpine iontophoretically. The<br>
pilocarpine stimulates production of sweat. The sweat is then collected and<br>
analyzed for its chloride content to detect the presence of the disease.<br>
Electrotransport devices generally employ two electrodes, positioned in intimate<br>
contact with some portion of the body, typically the skin. A first electrode, called<br>
the active or donor electrode, is used to deliver the therapeutic agent into the<br>
body. The second electrode, called the counter or return electrode, closes an<br>
electrical circuit with the first electrode through the body. A source of electrical<br><br>
energy such as a battery, supplies electric current to the body through the<br>
electrodes. For example, if the therapeutic agent to be delivered into the body is<br>
a positively charged cation, the anode is the active	<br><br>
electrode and the cathode is the counter electrode required to complete the circuit If the<br>
therapeutic agent to be delivered is a negatively charged anion, the cathode is the donor<br>
electrode and the anode is the counter electrode.<br>
A widely used electrotransport process, electromigration (also called<br>
iontophoresis), involves the electrically induced transport of charged ions (e.g., drug ions)<br>
through a body surface. Another type of electrotransport, called electroosmosis, involves<br>
the trans-body surface (e.g., transdermal) flow of a liquid under the influence of the<br>
applied electric field. Still another type of electrotransport process, called electroporation,<br>
involves forming transiently existing pores in a biological membrane by applying high<br>
voltage pulses. In any given electrotransport system, one or more of these processes may<br>
occur to some extent simultaneously.<br>
Most transdermal electrotransport devices have an anodic and cathodic<br>
electrode assembly. Each electrode assembly is comprised of an electrically conductive<br>
electrode in ion-transmitting relation with an ionically conductive reservoir which is<br>
placed in contact with the patient's skin during use. A hydrogel reservoir such as<br>
described in Webster, US Patent No. 4,383,529 is the preferred form of reservoir since<br>
hydrated gels are easier to handle and manufacture than liquid-filled reservoirs. Water is<br>
by far the preferred liquid solvent for use in such reservoirs. This is in part because many<br>
drug salts are water-soluble and in part because water has excellent biocompatability,<br>
making prolonged contact between the reservoir and the skin acceptable from an irritation<br>
standpoint<br>
The term "agent" is intended to have its broadest interpretation and is used<br>
to include any therapeutic agent or drug, as well as any body analyte, such as glucose.<br>
The terms "drug" and "therapeutic agent" are used interchangeably to refer to any<br>
therapeutically active substance that is delivered to a living organism to produce a<br>
desired, usually beneficial, effect. This includes therapeutic agents in all the major<br>
therapeutic areas including, but not limited to: anti-infectives such as antibiotics and<br>
antiviral agents; analgesics, including fentanyl, sufentanil, remifentanil, buprenorphine<br>
and analgesic combinations; anesthetics; anorexics; antiarthritics; antiasthmatic agents<br><br>
such as terbutaline; anticonvulsants; antidepressants; antidiabetic agents;<br>
antidiarrheals; antihistamines; anti-inflammatoiy agents; antimigraine preparations;<br>
antimotion sickness preparations such as scopolamine and ondansetron; antinauseants;<br>
antineoplastics; antiparkinsonism drugs; antipruritics; antipsychotics; antipyretics;<br>
antispasmodics, including gastrointestinal and urinary; anticholinergics;<br>
sympamornimetrics; xanthine derivatives; cardiovascular preparations, including<br>
calcium channel blockers such as nifedipine; beta blockers; beta-agonists such as<br>
dobutamine and ritodrine; antiarrythrnics; antihypertensives such as atenolol; ACE<br>
inhibitors such as ranitidine; diuretics; vasodilators, including general, coronary,<br>
peripheral, and cerebral; central nervous system stimulants; cough and cold<br>
preparations; decongestants; diagnostics; hormones such as parathyroid hormone;<br>
hypnotics; immunosuppressants; muscle relaxants; parasympatholytics;<br>
parasympathomimetrics; prostaglandins; proteins; peptides; psychostimulants;<br>
sedatives; and tranquilizers.<br>
The term "flexible" is intended to have its standard meaning which means<br>
that a material has the property of being able to be bent without breaking.<br>
Of particular interest in transdermal delivery is the delivery of analeesic<br>
drugs for the management of moderate to severe pain. Control of the rate and duration<br>
of drug delivery is particularly important for transdermal delivery of analgesic drugs to<br>
avoid the potential risk of overdose and the discomfort of an insufficient dosage. One<br>
class of analgesics that has found application in a transdermal delivery route is the<br>
synthetic opiates, a group of 4-aniline piperidines. The synthetic opiates, e.g., fentanyl<br>
and certain of its derivatives such as sufentanil, are particularly well suited for<br>
transdermal administration. These synthetic opiates are characterized by their rapid<br>
onset of analgesia, high potency, and short duration of action. They are estimated to be<br>
80 and 800 times, respectively, more potent than morphine. These drugs are weak<br>
bases, i.e., amines, whose major fraction is cationic in acidic media.<br>
Electrotransport devices use at least two electrodes that are in electrical<br>
contact with some portion of the skin, nails, mucous membrane, or other surface of the<br><br>
body. One electrode, commonly called the "donor" electrode, is the electrode from<br>
which the therapeutic agent is delivered into the body. The other electrode, typically<br>
termed the "counter" electrode, serves to close the electrical circuit through the body.<br>
For example, if the therapeutic agent to be delivered is a positively charged cation, then<br>
the anode is the donor electrode, while the cathode is the counter electrode, which<br>
serves to complete the circuit Alternatively, if a therapeutic agent is a negatively<br>
charged anion, the cathode is the donor electrode and the anode is the counter<br>
electrode. Additionally, bom the anode and cathode may be considered donor<br>
electrodes if both anionic and canonic therapeutic agent ions, or if uncharged dissolved<br>
therapeutic agent, are to be delivered.<br>
Furthermore, electrotransport delivery systems generally require at least<br>
one reservoir or source of the therapeutic agent to be delivered to the body/ Examples<br>
of such donor reservoirs include a pouch or cavity, a porous sponge or pad, and a<br>
hydrophilic polymer or a gel matrix. Such donor reservoirs are electrically connected<br>
to, and positioned between, the anode or cathode and the body surface, to provide a<br>
fixed or renewable source of one or more therapeutic agents or drugs. Electrotransport<br>
devices are powered by an electrical power source such as one or more batteries.<br>
Typically, at any one time, one pole of the power source is electrically connected to the<br>
donor electrode, while the opposite pole is electrically connected to the counter<br>
electrode. Since it has been shown that the rate of electrotransport drug delivery is<br>
approximately proportional to the electric current applied by the device, many<br>
electrotransport devices typically have an electrical controller that controls the voltage<br>
and/or current applied through the electrodes, thereby regulating the rate of drug<br>
delivery. These control circuits use a variety of electrical components to control the<br>
amplitude, polarity, timing, waveform shape, etc. of the electric current and/or voltage<br>
supplied by the power source. See, for example, McNichols et al., U.S. Patent No.<br>
5,047,007.<br>
To date, commercial transdermal electrotransport drug delivery devices<br>
(e.g., the Phoresor, sold by Iomed, Inc. of Salt Lake City, UT; the Dupel Iontophoresis<br>
System sold by Erapi, Inc. of St. Paul, MN; and the Webster Sweat Inducer, model<br><br>
3600, sold by Wescor, Inc. of Logan, UT) have generally utilized a desk-top electrical<br>
power supply unit and a pair of skin contacting electrodes. The donor electrode<br>
assembly contains a drug solution while the counter electrode assembly contains a<br>
solution of a biocompatible electrolyte salt. The power supply unit has electrical<br>
controls for adjusting the amount of electrical current applied through the electrodes.<br>
The "satellite" electrodes are connected to the electrical power supply unit by long<br>
(e.g., 1-2 meters) electrically conductive wires or cables. The wire connections are<br>
subject to disconnection and limit the patient's movement and mobility. Wires between<br>
electrodes and controls may also be annoying or uncomfortable to the patient. Other<br>
examples of desk-top electrical power supply units which use "satellite" electrode<br>
assemblies are disclosed in Jacobsen et al., U.S. Patent No. 4,141,359 (see Figures 3<br>
and 4); LaPrade, U.S. Patent No. 5,006,108 (see Figure 9); and Maurer et al., U.S.<br>
Patent No. 5,254,081.<br>
More recently, electrotransport delivery devices have become much<br>
smaller, particularly with the development of miniaturized integrated circuits and more<br>
powerful light weight batteries (e.g., lithium batteries). The advent of inexpensive<br>
miniaturized electronic circuitry and compact, high-energy batteries has meant that the<br>
entire device can be made small enough to be unobtrusively wom on the skin of the<br>
patient, under clothing. This allows" the patient to remain fully ambulatory and able to<br>
perform all normal activities, even during periods when the electrotransport device is<br>
actively delivering drug. Such small self-contained electrotransport delivery devices<br>
are disclosed for example in Tapper, U.S. Patent No. 5,224,927; Sibalis et al., U.S.<br>
Patent No. 5,224,928; and Haynes et al., U.S. Patent No. 5,246,418.<br>
Reference is now made to FIG. 1 which depicts an exploded view of an<br>
exemplary electrotransport device 10 having an activation switch in the form of a push<br>
button switch 12 and a display in the form of a light emitting diode (LED) 14. Device<br>
10 comprises an upper housing 16, a circuit board assembly 18, a lower housing 20,<br>
anode electrode 22, cathode electrode 24, anode reservoir 26, cathode reservoir 28 and<br>
skin-compatible adhesive 30. Upper housing 16 may have lateral wings 15, which<br>
assist in holding device 10 on a patient's skin. Upper housing 16, when molded with<br><br>
the lateral wings, is generally composed of rubber or other elastomeric material, such<br>
as an ethylene vinyl acetate (EVA), silicone, polyolefinic elastomers (Engage*), or<br>
similar material. Upper housing 16, if not molded with the lateral wings, could be<br>
made of a more rigid material such as sryrene, polypropylene, polyethylene or other<br>
similar material. Lower housing 20 is typically composed of a plastic or elastomeric<br>
sheet material (such as polyethylene terephthalate glycol (PETG) or polyethylene)<br>
which can be easily molded or thermoformed to form depressions for the reservoirs and<br>
the electrodes. The sheet material can easily be cut to form openings 23 and 23'<br>
therein. Alternately the lateral wings can be an integral part of the lower housing. In<br>
this case, the lower housing may be molded using an elastomeric material or<br>
thermoformed using a flexible material. Printed circuit board assembly 18 comprises<br>
an integrated circuit 19 coupled to discrete electrical components 40 and battery 32.<br>
Circuit board assembly 18 is attached to housing 16 by posts (not shown in-FIG. 1)<br>
passing through openings 13a and 13b, the ends of the posts being heated and/or melted<br>
in order to heat stake the circuit board assembly 18 to upper housing 16. Alternate<br>
forms of assembly include the use of snap fit components, ultrasonic welding, screws,<br>
rivets or friction fit. Lower housing 20 is attached to the upper housing 16 by means of<br>
adhesive 30, flie upper surface 34 of adhesive 30 being adhered to both lower housing<br>
20 and upper housing 16 including the bottom surfaces of wings 15, if present<br>
On the underside of circuit board assembly 18 is battery 32, which<br>
serves as the power source for the device and which may be a button cell battery, such<br>
as a lithium cell. The circuit outputs of the circuit board assembly 18 make electrical<br>
contact with the electrodes 24 and 22 through openings 23, 23' in the depressions 25,<br>
25' formed in lower housing 20 by means of electrically conductive adhesive 42,42'.<br>
Electrodes 22 and 24, in turn, are in direct electrical and/or mechanical contact with the<br>
top sides 44', 44 of drug reservoir 26 and the non-drug containing electrolyte reservoir<br>
28. The bottom sides 46', 46 of reservoirs 26,28 contact the patient's skin through the<br>
openings 29', 29 in adhesive 30. Upon depression of push button switch 12, the<br>
electronic circuitry on circuit board assembly 18 delivers a predetermined direct<br>
current (DC) to the electrodes/reservoirs 22, 26 and 24, 28 for a delivery interval of<br>
predetermined length.<br><br>
Electrotransport delivery devices are prepared, shipped, and stored (or<br>
stored, shipped, and stored), prescribed and then used. As a result, the devices must<br>
have components that have extended shelf lives that, in some instances, must comply<br>
with regulatory requirements. For instance, the U.S. Food and Drug Administration<br>
has shelf life requirements of from six to eighteen months or more for some materials.<br>
One complicating factor in achieving an extended shelf life is the stability of the<br>
system components when exposed to elevated temperatures. In order to achieve<br>
satisfactory dimensional stability of the elastomeric system components, the molding<br>
conditions as well as secondary manufacturing operations must be carefully optimized,<br>
requiring narrow ranges of process parameters, to avoid warpage, deformation and/or<br>
unacceptable dimensional changes. If the device housing should encounter elevated<br>
temperatures (i.e. over 40 Â°C) during storage or shipping these same undesirable<br>
deformations or dimensional changes may occur.<br>
Further, electrotransport delivery devices typically contain electronic<br>
components (e.g., integrated circuits, resistors, diodes capacitors, inductors, etc.),<br>
conductive circuit traces, and electrical as well as physical connections therebetween<br>
which can corrode or otherwise be degraded by water or water vapor. Devices such as<br>
device 10 shown in FIG. 1 have hydratable or hydrated reservoirs 26, 28. Thus,<br>
humidity or moisture from the hydrated reservoirs can permeate or leak through the<br>
reservoir housing during manufacturing and storage. The moisture can thus cause<br>
corrosion of the electronic and/or mechanical components within the device, thereby<br>
reducing the shelf life of the device. One source of permeation or leaks is around the<br>
electrodes or around the electrical leads or contacts, which must supply electric current<br>
and voltage from the battery into the relatively wet environment inside of the reservoir<br>
housing.<br>
In order to apply voltage from a power source to the donor reservoir, there<br>
must be some method or device used to place the power source in electrical<br>
communication with the donor reservoir.<br><br>
One method is to mold, punch, drill, or in some other manner fabricate an<br>
opening in the housing used to contain the drug reservoir. An electrode is then placed or<br>
adhered on the inside of the bousing, thus making the electrode accessible through the<br>
opening. The drug reservoir is then placed within the reservoir cavity so that it is in<br>
electrical contact with the electrode. Thereafter, electrical contact can be made with the<br>
drug reservoir via that portion of the electrode that is exposed by the opening in the<br>
reservoir housing.<br>
There are several critical points in the implementation of this method. All<br>
of which involve scaling the opening in the reservoir housing. Because the drug<br>
reservoirs are often largely water, there is tendency for this liquid, moisture and/or<br>
humidity to escape from the housing and corrode the electronic and/or mechanical<br>
components if there is not proper sealing between the electrode and the drug reservoir<br>
housing. Because these devices are shipped and stored in sealed pouches, any water or<br>
moisture escaping from the reservoir will be trapped in the interior of the device and<br>
expose the controller circuitry and other electrical components to the water. Water,<br>
particularly water containing electrolyte salts which are typically found in the drug<br>
reservoir, can be very corrosive and quite damaging to the device.<br>
One solution has been to develop dry or non-hydrated electrodes. See for<br>
example United States Patent Nos. 5,158,537; 5,288,289; 5,310,404; and 5,320,598.<br>
Because the electrode only needs to be hydrated during actual use by the patient during<br>
drug delivery, the device can be manufactured and stored with the reservoir in a dry or<br>
non-hydrated state. Then a bydrating liquid, with or without the agent dissolved therein,<br>
is added to the reservoir just prior to use. But there are a number of design considerations<br>
that must be taken into account when this approach is used and it introduces its own set<br>
of challenges. Problems arise regarding dehydrating and rehydrating without damaging<br>
me drug reservoir and assuring the adequate and timely resolubilization of the active<br>
agent upon rehydration.<br>
Other approaches have been to make the device resistant to moisture and<br>
corrosion. One step that has been taken to combat the corrosion problem has included<br><br>
gold plating the electrical and/or mechanical connectors (such as contacts or contact tabs)<br>
and circuit board traces. Such solutions are inherently expensive and add additional steps<br>
to the manufacturing process.<br>
Other tactics used to deal with the moisture and corrosion problem has<br>
been to seal the electronics in a conformal coating, to package the hydrogel separately<br>
and to include desiccant in the pouch containing the device.<br>
Use of conformal coatings requires an additional processing step which<br>
increases costs and production time. Packaging the drug reservoir gels separately also<br>
increases costs and production time and also includes additional steps for the patient who<br>
must then assemble the device prior to use. Desiccants in the device pouch also require<br>
additional components and also tend to dehydrate the gel reservoirs in the pouches which<br>
results in decreased efficiency when used by the patient<br>
Description of the Invention<br>
The present invention provides an electrotransport reservoir housing<br>
having a flexible conductive element integrally molded within the insulated housing so<br>
that a first portion of the element is within the housing and the second portion is outside<br>
of the housing. The incorporation of this flexible conductive element as part of the<br>
reservoir housing enables placing the drug reservoir and electrode, which are inside of the<br>
reservoir housing, in electrical communication with a power source outside of the<br>
reservoir, without the need for an opening to be formed in the reservoir housing after it<br>
has been formed. Because the molding process is performed at high heat and pressure,<br>
there is a very tight, liquid and moisture impermeable bond that is created between the<br>
material forming the reservoir housing and the conductive element This results in a<br>
reservoir housing that is essentially a single integral component that does not require the<br>
fabrication of openings or other passages through the housing which would require<br>
subsequent sealing. By having a conductive element molded into and through the<br>
housing during manufacture, it eliminates problems of water and/or moisture from the<br>
drug reservoir contained within the interior of me reservoir housing leaking through or<br>
otherwise coming in contact with the electrical and/or mechanical components outside of<br>
the reservoir housing.<br><br>
Brief Description of the Accompaning Drawings<br>
A better understanding of the present invention as well as other objects<br>
and advantages thereof will become apparent upon consideration of the following<br>
detailed description especially when taken with the accompanying drawings, wherein like<br>
numerals designate like parts throughout, and wherein:<br>
Figure 1 is an exploded view of a prior art electrotransport device;<br>
Figure 2 is a perspective view of the flexible conductive element;<br>
Figure 3 is a sectional view of a specific implementation of the invention; and<br>
Figure .4 is a sectional view of an embodiment similar to Fig. 3, but which<br>
also includes a circuit board.<br>
Modes for Carrying Out the Invention<br>
The following discussion will be made with reference to Figs. 2-4. The<br>
present invention calls for the use of a Flexible Conductor 100 which is comprised of<br>
Electrode End 103 and Contact End 107 and a Connecting Portion 102 which runs<br>
between the two ends. A conductive coating is applied to the surfaces of Electrode<br>
End 103 and Contact End 107 and the Connecting Portion 102. Each of the three<br>
regions may be coated with a different material because the coating for each region<br>
serves a different purpose and has different requirements.<br>
Electrode End 103, which will be located within the reservoir housing,<br>
will serve as part of the electrode assembly and will be coated with Electrode Coating<br>
104 which is a conductive material that fulfills the electrochemistry needs of a<br>
conductive surface located within the reservoir housing. Such material would typically<br>
be a Ag/AgCl ink. Alternatively, a separate Ag/AgCl electrode (not shown) may be<br>
positioned within the reservoir housing so as to be in direct contact with Electrode End<br>
103 and the reservoir gel or reservoir matrix. In mis case, a special coating on<br>
Electrode End 103 may not be required and any conductive coating that is suitable for<br>
use in the moisture rich environment of the reservoir housing may used.<br><br>
The Connecting Portion 102 is coated with Connecting Coating 106<br>
which, because of the physical deformations that are applied to this region, will need to<br>
be highly flexible. Such a coating would typically be any one of a number of flexible<br>
polymers containing conductive particles such as carbon black or powdered metal.<br>
Contact End 107 may be coated with Contact Coating 108, which will<br>
make electrical contact with other electrical components of the electrotransport device<br>
located outside of the reservoir housing. These typically include, but are not limited to<br>
the power source and current regulating circuitry. Contact Coating 108 will effectuate<br>
efficient electrically conductive contact with electrical contact pads or other points of<br>
contact, on a circuit board or other means of electrical communication which would<br>
contain one or more components such as the powen source (e.g. batteries), and current<br>
regulating circuitry.<br>
As shown in Figs. 3 and 4, Reservoir Housing 120 is molded around the<br>
Connecting Portion 102 of Flexible Conductor 100. Electrode End 103 is positioned<br>
within the reservoir cavity with the Electrode Coating 104 facing towards the open end<br>
of the Reservoir Housing 120. Electrode Coating 104 would therefore be in contact<br>
with the agent-containing reservoir (not shown) that would be placed within Reservoir<br>
Housing 120.<br>
A sufficient length of the Connecting Portion 102 is located outside of<br>
the Reservoir Housing 120 so that Flexible Conductor 100 can be bent or folded back<br>
on itself and be positioned along the upper Outer Surface 140 of Reservoir Housing<br>
120. Part of the Connecting Portion 102 is located outside of the Reservoir Housing<br>
120 and is called the Flexible Region 105. Because of the significant physical<br>
deformation required of Flexible Region 105, Connecting Coating 106 must be<br>
sufficiently flexible so that proper electrical conductivity can be maintained while<br>
being flexed and yet stay physically attached to Connecting Portion 102, even during<br>
significant bending and flexing.<br><br>
After Connecting Portion 102 been defoimed and Flexible<br>
Conductor 100 has been bent back on itself, Contact End 107 is now positioned with<br>
Contact Coating 108 facing away from Reservoir Housing 120. Typically, Contact<br>
Coating 108 is placed in electrical communication with an electrical Contact Pad 135<br>
located on Circuit Board 130, as shown in Fig. 4.. However, Contact Coating 108 may<br>
be placed in contact any of a number of standard electrical connections means well<br>
known in the industry.<br>
Though Contact End 107 and Circuit Board 130 are shown positioned<br>
above Reservoir Housing 120 in Figs. 3 and 4, the use of Flexible Conductor 100<br>
allows the placement of the Contact End 107 and Contact Coating 108 in any<br>
reasonable location relative to Reservoir Housing<br>
Though the embodiment shown describes an underlying flexible<br>
substrate with various coatings on top of the substrate, the scope of the invention does<br>
not require the use of separate coating layers and includes embodiments in which one<br>
or more of the various regions of Flexible Conductor 100: Electrode End 103, Contact<br>
End 107 and Connecting Portion 102 are made of a single layer of material which<br>
fulfills the required function for each region of the Flexible Conductor 100.<br>
It is further within the scope of the invention that Flexible<br>
Conductor 100 can be an integral component formed from a single type of conductive,<br>
flexible material.<br>
The above-described exemplary embodiments are intended to be<br>
illustrative in all respects, rather than restrictive, of the present invention. Thus, the<br>
present invention is capable of implementation in many variations and modifications that<br>
can be derived from the description herein by a person skilled in the art. All such<br>
variations and modifications are considered to be within the scope and spirit of the<br>
present invention.<br><br>
WE CLAIM<br>
1.	An electrotransport device comprising:<br>
a reservoir and a non-conductive housing for the reservoir that comprises<br>
a substantially flexible electrically conductive element integrally molded<br>
within the non-conductive housing,<br>
wherein a first portion of the conductive element is within the non-<br>
conductive housing and a second portion of the element is disposed on<br>
the outside of the non-conductive housing and extends thereform, and<br>
wherein a substantially liquid and moisture-impermeable bond is created<br>
between the material forming the non-conductive housing and the<br>
conductive element.<br>
2.	The electrotransport device as claimed in claim 1, wherein the non-<br>
conductive housing is a single integral component.<br>
3.	The electrotransport device as claimed in claim 2, wherein the<br>
electrotransport device is manufactured without the fabrication of<br>
openings or other passages through the non-conductive housing.<br><br>
4.	The electrotransport device as claimed in claim 1, wherein the conductive<br>
element comprises a substantially planar member.<br>
5.	The electrotransport device as claimed in claim 1, wherein the conductive<br>
element comprises a base member having a conductive coating disposed<br>
thereon.<br><br>
This invention relates to an electrotransport device comprising; a reservoir and a<br>
non-conductive housing for the reservoir that comprises a substantially flexible<br>
electrically conductive element integrally molded within the non-conductive<br>
housing, wherein a first portion of the conductive element is within the non-<br>
conductive housing and a second portion of the element is disposed on the<br>
outside of the non-conductive housing and extends thereform, and wherein a<br>
substantially liquid and moisture-impermeable bond is created between the<br>
material forming the non-conductive housing and the conductive element.</td>
			</tr>
		</table>	
		<br>
		<h3>Documents:</h3>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU4Ny1rb2xucC0yMDA1LWdyYW50ZWQtYWJzdHJhY3QucGRm" target="_blank" style="word-wrap:break-word;">1587-kolnp-2005-granted-abstract.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU4Ny1rb2xucC0yMDA1LWdyYW50ZWQtY2xhaW1zLnBkZg==" target="_blank" style="word-wrap:break-word;">1587-kolnp-2005-granted-claims.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU4Ny1rb2xucC0yMDA1LWdyYW50ZWQtY29ycmVzcG9uZGVuY2UucGRm" target="_blank" style="word-wrap:break-word;">1587-kolnp-2005-granted-correspondence.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU4Ny1rb2xucC0yMDA1LWdyYW50ZWQtZGVzY3JpcHRpb24gKGNvbXBsZXRlKS5wZGY=" target="_blank" style="word-wrap:break-word;">1587-kolnp-2005-granted-description (complete).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU4Ny1rb2xucC0yMDA1LWdyYW50ZWQtZHJhd2luZ3MucGRm" target="_blank" style="word-wrap:break-word;">1587-kolnp-2005-granted-drawings.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU4Ny1rb2xucC0yMDA1LWdyYW50ZWQtZXhhbWluYXRpb24gcmVwb3J0LnBkZg==" target="_blank" style="word-wrap:break-word;">1587-kolnp-2005-granted-examination report.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU4Ny1rb2xucC0yMDA1LWdyYW50ZWQtZm9ybSAxLnBkZg==" target="_blank" style="word-wrap:break-word;">1587-kolnp-2005-granted-form 1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU4Ny1rb2xucC0yMDA1LWdyYW50ZWQtZm9ybSAyLnBkZg==" target="_blank" style="word-wrap:break-word;">1587-kolnp-2005-granted-form 2.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU4Ny1rb2xucC0yMDA1LWdyYW50ZWQtZm9ybSAyNi5wZGY=" target="_blank" style="word-wrap:break-word;">1587-kolnp-2005-granted-form 26.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU4Ny1rb2xucC0yMDA1LWdyYW50ZWQtZm9ybSAzLnBkZg==" target="_blank" style="word-wrap:break-word;">1587-kolnp-2005-granted-form 3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU4Ny1rb2xucC0yMDA1LWdyYW50ZWQtZm9ybSA1LnBkZg==" target="_blank" style="word-wrap:break-word;">1587-kolnp-2005-granted-form 5.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU4Ny1rb2xucC0yMDA1LWdyYW50ZWQtcmVwbHkgdG8gZXhhbWluYXRpb24gcmVwb3J0LnBkZg==" target="_blank" style="word-wrap:break-word;">1587-kolnp-2005-granted-reply to examination report.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTU4Ny1rb2xucC0yMDA1LWdyYW50ZWQtc3BlY2lmaWNhdGlvbi5wZGY=" target="_blank" style="word-wrap:break-word;">1587-kolnp-2005-granted-specification.pdf</a></p>
		<br>
		<div class="pull-left">
			<a href="228116-delivery-system.html">&laquo; Previous Patent</a>
		</div>
		<div class="pull-right">
			<a href="228118-method-and-apparatus-for-manufacturing-an-electric-pole.html">Next Patent &raquo;</a>
		</div>			
	</div><!-- /span8 -->
	<div class="span4">
		<div class="well infobox">
			<table class="table table-condensed">
				<tr>
					<th>Patent Number</th>
					<td>228117</td>
				</tr>
				<tr>
					<th>Indian Patent Application Number</th>
					<td>1587/KOLNP/2005</td>
				</tr>
				<tr>
					<th>PG Journal Number</th>
					<td>05/2009</td>
				</tr>
				<tr>
					<th>Publication Date</th>
					<td>30-Jan-2009</td>
				</tr>
				<tr>
					<th>Grant Date</th>
					<td>28-Jan-2009</td>
				</tr>
				<tr>
					<th>Date of Filing</th>
					<td>09-Aug-2005</td>
				</tr>
				<tr>
					<th>Name of Patentee</th>
					<td>ALZA CORPORATION</td>
				</tr>
				<tr>
					<th>Applicant Address</th>
					<td>1900 CHARLESTON ROAD, M 10-3B, P.O. BOX 7210, MOUNTAIN VIEW, CA</td>
				</tr>
				<tr>
					<td colspan=2>
								<h5>Inventors:</h5>
								<table class="table">
									<tr>
										<th>#</th>
										<th>Inventor's Name</th>
										<th>Inventor's Address</th>
									</tr>

										<tr>
											<td>1</td>
											<td>CYORY, RICHARD, J.</td>
											<td>10 CURRY LANE, SUDBURY, MA 01776</td>
										</tr>
								</table>
					</td>
				</tr>
				<tr>
					<th>PCT International Classification Number</th>
					<td>A61N 1/30</td>
				</tr>
				<tr>
					<th>PCT International Application Number</th>
					<td>PCT/US2004/009831</td>
				</tr>
				<tr>
					<th>PCT International Filing date</th>
					<td>2004-03-30</td>
				</tr>
				<tr>
					<td colspan=2>
						<h5>PCT Conventions:</h5>
						<table class="table">
							<tr>
								<th>#</th>
								<th>PCT Application Number</th>
								<th>Date of Convention</th>
								<th>Priority Country</th>
							</tr>

								<tr>
									<td>1</td>
									<td>60/459,539</td>
									<td>2003-03-31</td>
								    <td>U.S.A.</td>
								</tr>

						</table>
					</td>
				</tr>
			</table>
		</div><!-- /well -->
	</div><!-- /span4 -->
</div><!-- /row-fluid -->

        </div>

      </div><!--/row-->

      <footer class="footer">

        <style>
        .allindianpatents-footer { width: 320px; height: 50px; }
        @media(min-width: 500px) { .allindianpatents-footer { width: 468px; height: 60px; } }
        @media(min-width: 800px) { .allindianpatents-footer { width: 728px; height: 90px; } }
        </style>
        <center>
        </center>

        <p>&copy; All Indian Patents, 2013-2021.</p>
        <p>Patent data available in the public domain from Indian Patents Office, Department of Industrial Policy and Promotions, Ministry of Commerce and Industry, Government of India.</p>
      </footer>

    </div> <!-- /container -->

    <!-- Javascripts
    ================================================== -->
    <!-- Placed at the end of the document so the pages load faster -->
    <script src="../assets/application-95f297ff0d8d2015987f04b30593c800.js" type="text/javascript"></script>

    <!-- Start of StatCounter Code for Default Guide -->
    <script type="text/javascript">
    var sc_project=8902313; 
    var sc_invisible=1; 
    var sc_security="3c1f8147"; 
    var scJsHost = (("https:" == document.location.protocol) ?
    "https://secure." : "http://www.");
    document.write("<sc"+"ript type='text/javascript' src='" +
    scJsHost+
    "statcounter.com/counter/counter.js'></"+"script>");
    </script>
    <noscript><div class="statcounter"><a title="web stats"
    href="http://statcounter.com/free-web-stats/"
    target="_blank"><img class="statcounter"
    src="http://c.statcounter.com/8902313/0/3c1f8147/1/"
    alt="web stats"></a></div></noscript>
    <!-- End of StatCounter Code for Default Guide -->

    <script>
      (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
      (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
      m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
      })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

      ga('create', 'UA-244143-31', 'allindianpatents.com');
      ga('send', 'pageview');

    </script>

  </body>

<!-- Mirrored from www.allindianpatents.com/patents/228117-an-electrotransport-device by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 08:41:20 GMT -->
</html>
